A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumorBEX, Axel; MALLO, Henk; KERST, Martijn et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 7, pp 713-719, issn 0340-7004, 7 p.Article

Interferon alpha 2b as medical selection for nephrectomy in patients with synchronous metastatic renal cell carcinoma : A consecutive studyBEX, Axel; KERST, Martyn; MALLO, Henk et al.European urology. 2006, Vol 49, Num 1, pp 76-81, issn 0302-2838, 6 p.Article

Determination of Sunitinib and Its Active Metabolite N-Desethylsunitinib in Sweat of a PatientLANKHEET, Nienke A. G; BLANK, Christian U; MALLO, Henk et al.Journal of analytical toxicology. 2011, Vol 35, Num 8, pp 558-565, issn 0146-4760, 8 p.Article

The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand―foot syndromeLANKHEET, Nienke A. G; HUITEMA, Alwin D. R; MALLO, Henk et al.European journal of clinical pharmacology. 2013, Vol 69, Num 12, pp 2065-2072, issn 0031-6970, 8 p.Article

On the role of melanoma-specific CD8⁺ T-cell immunity in disease progression of advanced-stage melanoma patientsVAN OIJEN, Monique; BINS, Adriaan; HAANEN, John et al.Clinical cancer research. 2004, Vol 10, Num 14, pp 4754-4760, issn 1078-0432, 7 p.Article

T-Cell Immune Function in Tumor, Skin, and Peripheral Blood of Advanced Stage Melanoma Patients: Implications for ImmunotherapyTJIN, Esther P. M; KONIJNENBERG, Debby; HAANEN, John B. A. G et al.Clinical cancer research (Print). 2011, Vol 17, Num 17, pp 5736-5747, issn 1078-0432, 12 p.Article

Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patientsBINS, Adriaan; MALLO, Henk; SEIN, Johan et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 2, pp 234-239, issn 1524-9557, 6 p.Article

Brain Metastases in Patients With Renal Cell Cancer Receiving New Targeted TreatmentHELGASON, Helgi H; MALLO, Henk A; DROOGENDIJK, Helga et al.Journal of clinical oncology. 2008, Vol 26, Num 1, pp 152-154, issn 0732-183X, 3 p.Article